CSL Limited (CSL) To Go Ex-Dividend on September 8th

CSL Limited (ASX:CSL) announced a final dividend on Thursday, September 5th, MarketIndexAU reports. Shareholders of record on Tuesday, October 1st will be given a dividend of 2.203 per share on Tuesday, October 1st. This represents a yield of 0.73%. The ex-dividend date is Sunday, September 8th. This is a positive change from CSL’s previous final dividend of $1.99.

CSL Stock Performance

The company has a debt-to-equity ratio of 62.80, a quick ratio of 1.68 and a current ratio of 2.17.

Insider Activity at CSL

In other news, insider Carolyn Hewson bought 193 shares of the firm’s stock in a transaction on Friday, August 16th. The stock was acquired at an average cost of A$305.34 ($207.71) per share, with a total value of A$58,930.04 ($40,088.46). In other CSL news, insider Carolyn Hewson bought 193 shares of the business’s stock in a transaction on Friday, August 16th. The shares were acquired at an average cost of A$305.34 ($207.71) per share, for a total transaction of A$58,930.04 ($40,088.46). Also, insider Paul McKenzie purchased 8,275 shares of the firm’s stock in a transaction dated Tuesday, September 3rd. The stock was acquired at an average price of A$306.03 ($208.18) per share, with a total value of A$2,532,398.25 ($1,722,719.90). 0.30% of the stock is currently owned by insiders.

About CSL

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.